Analysis of phosphorylation of pRB and its regulatory proteins in breast cancer

Journal of Clinical Pathology

Volumn 50, Issue 5, 1997, Pages 407-412

  Wakasugi, Eijiro ^a   Kobayashi, Tetsuro ^b   Tamaki, Yasuhiro ^a   Nakano, Yoshiaki ^a   Ito, Yasuhiro ^a   Miyashiro, Isao ^a   Komoike, Yoshifumi ^a   Miyazaki, Michihiko ^a   Takeda, Tsutomu ^a   Monden, Takushi ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA NATIONAL HOSPITAL   (Japan)

Author keywords

Breast cancer; Cdk2; Cyclin E; P21 Cip1; PRB

Indexed keywords

ONCOPROTEIN;

ARTICLE; BREAST BIOPSY; BREAST CANCER; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

EID: 8544230694     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.5.407     Document Type: Article

References (37)

1. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallic BL, et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983;305:779-84.
2. Lee EY-HP, To H, Shew J-Y, Bookstein R, Scully P, Lee W-H. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 1988;241:218-21.
3. T'Ang A, Verley JM, Chakraborty S, Murphree AL, Hung Y-K T. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 1988;242:263-6.
4. Varley JM, Armour J, Swallow JE, Jeffreys AJ, Ponder BAJ, T'Ang A, et al. The retinoblastorna gene is frequently altered leading to loss of expression in primary breast tumors. Oncogene 1989;4:725-9.
5. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi E, Sakamoto G, et al. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Ka 1990;50:7184-9.
6. Borg A, Zhang Q-X, Alm P, Olsson H, Sellberg G. The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res 1992;52:2991-4.
7. Lee WH, Bookstain R, Hong F, Young LJ, Shew JY, Lee EYHP. Human retinoblastoma susceptibility gene: cloning, identification and sequence. Science 1987;235:1394-9.
8. Buchkovich K, Duffy LA, Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 1989;t58:1097-105.
9. Chellapan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991;65:1053-61.
10. Hiebert SW, Challappan SP, Horowitz JM, Nevins JR. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of F2F. Genes Dev 1992;6:177-85.
11. Akiyama T, Ohuchi T, Sumida S, Matsumoto K, Toyoshima K. Phosphorylation of the retinoblastoma protein by cdk2. Proc Natl Acad Sci USA 1992;89:7900-4.
12. Kitagawa M, Saitoh S, Ogino H, Okabe T, Matsumoto H, Okuyama A, et al. cdc2-like kinase is associated with the retinoblastoma protein. Oncogene 1992;7:1067-74.
13. Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M, et al. Human cyclin F, a new cyclin that interacts with two members of the CDC2 gene family. Cell 1991;66:1217-18.
14. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, et al. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 1992;257:1689-94.
15. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-Interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-16.
16. Sawan A, Randall B, Angus B, Wright C, Henry JA, Ostrowski J, et al. Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: an immunohistochemical study. J Pathol 1992;168:23-8.
17. Trudel M, Mulligan L, Cavenee W, Margolese R, Cote J, Gariepy G. Retinoblastoma and p53 gene product expression in breast carcinoma. Hum Pathol 1992;23:1388-94.
18. Eiston CW. The assessment of histological differentiation in breast cancer. Aust NZ J Surg 1984;54:11-15.
19. Elston CW. Pathological aspects of breast cancer screening. Aust NZ J Surg 1988;58:355-63.
20. Meyerson M, Enders GH, Wu C-L, Su L-K, Gorka C, et al. A family of cdc2-related protein kinases. EMBO J 1992;11: 2909-17.
21. DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang C-M, et al. SV40 large T antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988;54:275-83.
22. Ludlow JW, DeCaprio JA, Huang CM, Lee WH, Paucha E, Livingston DM. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 1989;56:57-65.
23. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 1992;70:993-1006.
24. Sherr CJ. Mammalian G1 cyclins. Cell 1993;73:1059-65.
25. Keyomarsi K, Pardee AB. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 1993; 90:1112-6.
26. Murray AW, Kirschner MW. Dominoes and clocks: the union of two news of the cell cycle. Science 1989;246:614-21.
27. Nurse P. Universal control mechanism regulating onset of M-phase. Nature 1990;344:503-8.
28. Mailer JL, Mitotic control. Curr Opin Cell Biol 1991;3:269-75.
29. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parson R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
30. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994;54:3391-5.
31. Jiang H, Lin J, Su ZZ, Collart HR, Huberman E, Fisher PB. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 1994;9:3397-406.
32. Sheikh MS, Li SX, Shao ZM, Ordonez JV, Fontana JA. Mechanisms of regulation of WAElCIPl gene expression in human carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 1994;9:3407-14.
33. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, et al. p53-independent expression of p21/CIP1 in muscle and other terminally differentiating cells. Science 1995; 267:1024-7.
34. Zhang W, Grasso L, McClain GD, Gambel AM, CHA Y, Travali S, et al. p53-independent induction of WAE1/CTP1 in human leukemia cells is correlated with growth arrest accompanying monocyte macropharge differentiation. Cancer Res 1995;55:668-74.
35. Wakasugi E, Kobayashi T, Tamaki Y, ho Y, Miyashiro I, Komoike Y, et al. p21 (Waf1/Cip1) and p53 protein expression in breast cancer. Am J Clin Pathol. [In press.]
36. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-7.
37. Polyak K, Kato J, Solomon MJ, Sherr CJ, Massague J, Roberts JM, et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 1994;8:9-22.